Biogen Announces New Hope for Alzheimer’s Drug Candidate Aducanumab
On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to the FDA to seek approval
October 22, 2019
On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to the FDA to seek approval
On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to the FDA to seek approval
On October 22, 2019, the biopharmaceutical company, Biogen, announced that they will be going to the FDA to seek approval
The 2019 Research Rally Breakfast at the NDSC Annual Convention was attended by 400 families of loved ones with DS
A webinar with the Alzheimer’s Association about what people with Down syndrome and their families need to know about the
In the next couple of months, LuMind IDSC will launch the LIFE-DSR (Longitudinal Investigation for Enhancing Down Syndrome Research) study.
The LuMind IDSC Foundation is excited to welcome a new Research Partner to the community! BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today
We were sent a question about seizures in a person with Down syndrome who developed Alzheimer’s disease. The individual continues
The video below is a recording of a presentation called “Alzheimer’s Disease in Down Syndrome” given by Brian Chicoine, MD
Giving back is not new to John’s Crazy Socks (JCS), who just announced they are donating $2 from every sale